Meditope Biosciences Lands $1,624,080 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8eb725af-5ffc-4623-a08f-7385955d54ad - Date
10/9/2015 - Company Name
Meditope Biosciences - Mailing Address
301 North Lake Avenue Pasadena, CA 91101 USA - Company Description
Discovered at City of Hope, Meditope’s technology is capable of turning any monoclonal antibody (mAb) into a proprietary, site-specific Lego-like system that is able to attach and detach drugs to antibodies without the need for chemical conjugation. - Website
http://www.meditope.com - Transaction Type
Venture Equity - Transaction Amount
$1,624,080 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt. - M&A Terms
- Venture Investor
Undisclosed
